Peter A. Campochiaro, MD: RGX-314 Gene Therapy Phase 1/2a Data for Wet AMD.

AI Smart Glasses Show Promise, Limitations as Aid for Patients With Low Vision

Good accuracy for recognizing common objects, mixed results by object size, colors, text, money

Loss of Payment Assistance for AMD Drugs Strains Patients and Ophthalmologists

— Pervasive "unsustainable" clinical practices amid cat-and-mouse game with funding availability

Mindfulness App Eases Mental Burden in Eye Disease

A digital mindfulness-based intervention significantly reduces symptoms of anxiety and depression and perceived stress in adults with noninfectious uveitis, a clinical trial shows.

Families Traveling for Uveitis Screenings Face Higher Costs

Patients who lived more than 30 miles away from their specialists had median annual expenses over $400 in Tennessee and over $300 in California.

A Faster Path to an Artificial Eye

3D printing can greatly improve access to the prosthetics.

Gene-Agnostic Therapy Sees 3-Year Gain in Severe Vision Loss

A treatment that targets dysfunctional photoreceptors regardless of the underlying genetic mutation leads to improved functional vision in advanced severe vision loss.

Navigating Sustained Delivery in nAMD: An Interactive Clinical Decision-Making Simulation

Navigating Sustained Delivery in nAMD: An Interactive Clinical Decision-Making Simulation

Navigating Sustained Delivery in DME: An Interactive Clinical Decision-Making Simulation

Navigating Sustained Delivery in DME: An Interactive Clinical Decision-Making Simulation

Beyond Intravitreal Injections: Advancing Retinal Vascular Disease Care With Sustained Delivery Therapies

Beyond Intravitreal Injections: Advancing Retinal Vascular Disease Care With Sustained Delivery Therapies

Mock P&T: Applying the Latest Evidence to Advance Managed Care Decision-Making in Retinal Vascular Disease

Mock P&T: Applying the Latest Evidence to Advance Managed Care Decision-Making in Retinal Vascular Disease

Focus Aligned: Patient Selection and Counseling for Pharmacologic Presbyopia Therapies

Focus Aligned: Patient Selection and Counseling for Pharmacologic Presbyopia Therapies

Focus Reengineered: Mechanisms and Clinical Data for Pharmacologic Presbyopia Therapies

Focus Reengineered: Mechanisms and Clinical Data for Pharmacologic Presbyopia Therapies

Precision Ocular Care: Integrating Oncology and Eyecare to Conquer Cancer Therapy-Related Toxicities

Precision Ocular Care: Integrating Oncology and Eyecare to Conquer Cancer Therapy-Related Toxicities

AAO: American Academy of Ophthalmology

ASRS: American Society of Retina Specialists

ARVO Video Pearls: Video Pearls From The Association for Research in Vision and Ophthalmology